BioCentury
ARTICLE | Company News

SkyePharma, Mundipharma sales and marketing update

February 17, 2014 8:00 AM UTC

SkyePharma said Mundipharma launched flutiform fluticasone/formoterol in France to treat asthma. The launch triggered a €3 million ($4.1 million) milestone payment to SkyePharma from Mundipharma. The price for flutiform is €30.88 ($42.14) per inhaler for 50 µg fluticasone/5 µg formoterol and €39.25 ($53.56) per inhaler for 125 µg fluticasone/5 µg formoterol. Each inhaler provides 120 doses over 30 days. A single dose is two inhalations. ...